GWSG
VRTX icon

GPS Wealth Strategies Group’s Vertex Pharmaceuticals VRTX Stock Holding History

GPS Wealth Strategies Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$135K Sell
297
-599
-67% -$258K 0.11% 122
2025
Q3 		$351K Sell
896
-163
-15% -$68.1K 0.04% 245
2025
Q2 		$471K Sell
1,059
-10
-0.9% -$4.61K 0.05% 189
2025
Q1 		$518K Sell
1,069
-44
-4% -$20.5K 0.07% 164
2024
Q4 		$448K Sell
1,113
-87
-7% -$40.3K 0.06% 185
2024
Q3 		$558K Buy
1,200
+72
+6% +$34.6K 0.07% 166
2024
Q2 		$529K Buy
1,128
+351
+45% +$152K 0.08% 154
2024
Q1 		$325K Buy
777
+438
+129% +$185K 0.05% 197
2023
Q4 		$138K Buy
339
+46
+16% +$17K 0.03% 297
2023
Q3 		$102K Buy
293
+3
+1% +$1.05K 0.02% 359
2023
Q2 		$102K Hold
290
– – 0.02% 365
2023
Q1 		$91.4K Buy
+290
New +$87K 0.02% 366
2022
Q4 		– Sell
-172
Closed -$50K – 1058
2022
Q3 		$50K Buy
172
+23
+15% +$6.62K 0.01% 432
2022
Q2 		$42K Hold
149
– – 0.01% 478
2022
Q1 		$39K Buy
149
+76
+104% +$18K 0.01% 465
2021
Q4 		$16K Buy
73
+48
+192% +$9.33K ﹤0.01% 643
2021
Q3 		$5K Buy
+25
New +$4.88K ﹤0.01% 846

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

GPS Wealth Strategies Group's VRTX Position: Q4 2025 in Review

GPS Wealth Strategies Group reduced its Vertex Pharmaceuticals (VRTX) stake by 67% in Q4 2025, selling an estimated $258K and leaving 297 shares worth $135K. The position accounts for 0.11% of the portfolio, ranked #122.

GPS Wealth Strategies Group first reported a position in VRTX in Q3 2021 and has held it in 17 quarters since. The position peaked at $558K in Q3 2024. 1,668 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

  • GPS Wealth Strategies Group held 297 shares of Vertex Pharmaceuticals worth $135K as of Q4 2025.
  • GPS Wealth Strategies Group sold 599 Vertex Pharmaceuticals shares in Q4 2025, an estimated $258K.
  • Vertex Pharmaceuticals made up 0.11% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #122 holding.
  • GPS Wealth Strategies Group first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 17 quarters since.
  • GPS Wealth Strategies Group's Vertex Pharmaceuticals position peaked at $558K in Q3 2024.
  • 1,668 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.